PUBLISHER: Acute Market Reports | PRODUCT CODE: 1388486
PUBLISHER: Acute Market Reports | PRODUCT CODE: 1388486
Preclinical CRO Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
The preclinical contract research organization (CRO) market is expected to grow at a CAGR of 8% during the forecast period of 2023 to 2031. The preclinical CROs play a crucial role in supporting the pharmaceutical and life sciences industries by providing specialized research services. From 2023 to 2031, this market is expected to witness substantial growth driven by factors such as the increasing adoption of patient-derived models in preclinical research and the expanding clientele base, including biopharmaceutical companies, government and academic institutes, and medical device companies. In conclusion, the preclinical CRO market is set for substantial growth from 2023 to 2031, driven by the increasing adoption of patient-derived models in preclinical research and the expanding clientele base comprising biopharmaceutical companies, government and academic institutes, and medical device companies. While regulatory challenges pose a restraint, the market's overall outlook is promising, with specific model types, end-use segments, regions, and key players contributing to its trajectory.
Increasing Adoption of Patient-Derived Models
The rising adoption of patient-derived models in preclinical research is a significant driver of the preclinical CRO market. Patient-derived models, including Patient-Derived Organoid (PDO) Models and Patient-Derived Xenograft Models, have gained prominence due to their ability to closely mimic human physiology and disease pathology. These models are instrumental in evaluating drug efficacy, toxicity, and personalized treatment strategies. In 2022, the market witnessed a surge in demand for preclinical research services utilizing patient-derived models, reflecting the growing interest in precision medicine and tailored therapeutics. This trend is expected to continue from 2023 to 2031, with both PDO and Patient-Derived Xenograft Models playing a pivotal role in advancing drug development and disease understanding.
Expanding Clientele Base
The preclinical CRO market is experiencing growth due to an expanding clientele base. Biopharmaceutical companies, government and academic institutes, and medical device companies are increasingly relying on CRO services to accelerate their preclinical research programs. Biopharmaceutical companies, in particular, are driving demand by outsourcing a significant portion of their preclinical activities to specialized CROs. In 2022, the market benefited from this trend, with CROs catering to the diverse needs of their clients. Looking ahead to 2023 to 2031, the market is expected to witness continued growth, with Biopharmaceutical Companies as the primary end users, followed by Government and Academic Institutes and Medical Device Companies, further solidifying their reliance on CRO expertise.
Restraint - Regulatory Challenges
Despite the promising growth prospects, the preclinical CRO market faces regulatory challenges that can impede its progress. Regulatory agencies, both national and international, impose stringent guidelines and requirements on preclinical research, including the use of animal models and ethical considerations. Adhering to these regulations demands rigorous compliance and documentation, which can be time-consuming and resource-intensive. Market players must navigate this complex regulatory landscape, ensuring that their services meet the highest ethical and quality standards. Overcoming regulatory challenges is essential to maintain the trust of clients and regulatory authorities and ensure the long-term sustainability of the preclinical CRO market.
Market Segmentation by Model Type (PDO Model, Patient-Derived Xenograft Model):PDO Model Dominates the Market
The preclinical CRO market offers a range of model types to cater to the diverse needs of researchers and clients.
Patient-Derived Organoid (PDO) Model: PDO models represent a cutting-edge approach in preclinical research, allowing for the cultivation of three-dimensional organoid structures derived from patient tissues. In 2022, PDO models gained prominence in the market, offering a high-fidelity representation of human physiology and disease. This model type is expected to continue its growth trajectory, with both the highest revenue and CAGR, from 2023 to 2031, as researchers increasingly recognize their potential in drug testing and personalized medicine.
Patient-Derived Xenograft Model: Patient-Derived Xenograft (PDX) models involve the transplantation of patient tumor tissues into immunodeficient mice to study cancer biology and evaluate drug responses. In 2022, PDX models played a crucial role in cancer research and drug development, contributing to the market's growth. While the CAGR for PDX models is also significant, it is expected to maintain steady revenue contributions throughout the forecast period, reflecting their established role in oncology research and therapeutic evaluation.
Market Segmentation by End-Use (Biopharmaceutical Companies, Government and Academic Institutes, Medical Device Companies):Biopharmaceutical Companies Dominate the Market
The preclinical CRO market serves a diverse clientele, each with specific research needs and objectives.
Biopharmaceutical Companies: Biopharmaceutical companies are the primary end users of preclinical CRO services. In 2022, these companies relied on CRO expertise to accelerate drug discovery and development, driving the market's growth. Biopharmaceutical companies are expected to maintain their dominant position as the largest client base, both in terms of revenue and CAGR, from 2023 to 2031. Their ongoing demand for preclinical research services underscores the critical role of CROs in the drug development pipeline.
Government and Academic Institutes: Government and academic institutes play a vital role in advancing scientific knowledge and conducting preclinical research. In 2022, these entities utilized CRO services to support their research initiatives and secure funding for scientific projects. While the CAGR for this segment is substantial, revenue contributions are expected to remain consistent, reflecting the cyclical nature of research funding and academic collaborations.
Medical Device Companies: Medical device companies are increasingly turning to preclinical CROs to assess the safety and efficacy of their products. In 2022, this segment contributed to the market's growth by seeking CRO expertise in preclinical testing and regulatory submissions. The CAGR for Medical Device Companies is projected to be significant, reflecting the growing importance of preclinical evaluations in the medical device industry. Revenue contributions are expected to increase steadily as medical device companies prioritize safety and compliance in their product development processes.
APAC to Lead the Growth during the Forecast Period
The preclinical CRO market exhibits regional variations in trends, growth rates, and revenue distribution across different geographical areas. North America is expected to maintain its position as the region with the highest revenue percentage, reflecting its strong presence of biopharmaceutical companies and research institutions. Europe and Asia-Pacific are also anticipated to experience steady growth, driven by an expanding pharmaceutical and life sciences sector. Asia-Pacific is projected to showcase the highest CAGR during the forecast period from 2023 to 2031, as the region gains prominence in the global preclinical research landscape.
Market Competition to Intensify during the Forecast Period
The preclinical CRO market is characterized by intense competition among key players, with several leading companies driving innovation and market growth. In 2022, these companies reported significant revenues, and their strategies are expected to continue shaping the market from 2023 to 2031.
Covance Inc. (Labcorp): Covance Inc., a subsidiary of Labcorp, is a prominent player in the preclinical CRO market, known for its comprehensive range of research services. In 2022, the company reported substantial revenues, reflecting its strong market presence. Covance's key strategy revolves around continuous innovation and expanding its service portfolio to meet evolving research needs.
Charles River Laboratories International, Inc.: Charles River Laboratories International, Inc. is a renowned player in the preclinical CRO market, offering a wide array of research services. In 2022, the company reported strong revenues, driven by its commitment to scientific excellence. Charles River's competitive strategy focuses on expanding its global footprint and investing in advanced technologies to enhance preclinical research capabilities.
Syngene International Limited: Syngene International Limited is a leading player in the preclinical CRO market, specializing in drug discovery and development services. In 2022, the company reported robust revenues, reflecting its dedication to research innovation. Syngene's key strategy centers on strategic partnerships and collaborations with biopharmaceutical companies to accelerate drug development.
Historical & Forecast Period
This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofPreclinical CRO market are as follows:
- Research and development budgets of manufacturers and government spending
- Revenues of key companies in the market segment
- Number of end users and consumption volume, price and value.
Geographical revenues generate by countries considered in the report:
Micro and macro environment factors that are currently influencing the Preclinical CRO market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
Market Segmentation
Service
- Bioanalysis and DMPK studies
- In vitro ADME
- In-vivo PK
- Toxicology Testing
- GLP
- Non-GLP
- Compound Management
- Process R&D
- Custom Synthesis
- Others
- Chemistry
- Medicinal Chemistry
- Computation Chemistry
- Safety Pharmacology
- Others
Model Type
- Patient Derived Organoid (PDO) Model
- Patient derived xenograft model
End-Use
- Biopharmaceutical Companies
- Government and Academic Institutes
- Medical Device Companies
Region Segment (2021-2031; US$ Million)
- North America
- U.S.
- Canada
- Rest of North America
- UK and European Union
- UK
- Germany
- Spain
- Italy
- France
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- GCC
- Africa
- Rest of Middle East and Africa
Key questions answered in this report:
- What are the key micro and macro environmental factors that are impacting the growth of Preclinical CRO market?
- What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
- Estimated forecast and market projections up to 2031.
- Which segment accounts for the fastest CAGR during the forecast period?
- Which market segment holds a larger market share and why?
- Are low and middle-income economies investing in the Preclinical CRO market?
- Which is the largest regional market for Preclinical CRO market?
- What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
- Which are the key trends driving Preclinical CRO market growth?
- Who are the key competitors and what are their key strategies to enhance their market presence in the Preclinical CRO market worldwide?
Table of Contents
1. Preface
- 1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted
2. Executive Summary
- 2.1. Market Snapshot: Global Preclinical CRO Market
- 2.2. Global Preclinical CRO Market, By Service, 2022 (US$ Million)
- 2.3. Global Preclinical CRO Market, By Model Type, 2022 (US$ Million)
- 2.4. Global Preclinical CRO Market, By End-Use, 2022 (US$ Million)
- 2.5. Global Preclinical CRO Market, By Geography, 2022 (US$ Million)
- 2.6. Attractive Investment Proposition by Geography, 2022
3. Preclinical CRO Market: Competitive Analysis
- 3.1. Market Positioning of Key Preclinical CRO Market Vendors
- 3.2. Strategies Adopted by Preclinical CRO Market Vendors
- 3.3. Key Industry Strategies
- 3.4. Tier Analysis 2022 Versus 2031
4. Preclinical CRO Market: Macro Analysis & Market Dynamics
- 4.1. Introduction
- 4.2. Global Preclinical CRO Market Value, 2021 - 2031, (US$ Million)
- 4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
- 4.4. Impact Analysis of Drivers and Restraints
- 4.5. See-Saw Analysis
5. Preclinical CRO Market: By Service, 2021-2031, USD (Million)
- 5.1. Market Overview
- 5.2. Growth & Revenue Analysis: 2022 Versus 2031
- 5.3. Market Segmentation
- 5.3.1. Bioanalysis and DMPK studies
- 5.3.1.1. In vitro ADME
- 5.3.1.2. In-vivo PK
- 5.3.2. Toxicology Testing
- 5.3.2.1. GLP
- 5.3.2.2. Non-GLP
- 5.3.3. Compound Management
- 5.3.3.1. Process R&D
- 5.3.3.2. Custom Synthesis
- 5.3.3.3. Others
- 5.3.4. Chemistry
- 5.3.4.1. Medicinal Chemistry
- 5.3.4.2. Computation Chemistry
- 5.3.5. Safety Pharmacology
- 5.3.6. Others
- 5.3.1. Bioanalysis and DMPK studies
6. Preclinical CRO Market: By Model Type, 2021-2031, USD (Million)
- 6.1. Market Overview
- 6.2. Growth & Revenue Analysis: 2022 Versus 2031
- 6.3. Market Segmentation
- 6.3.1. Patient Derived Organoid (PDO) Model
- 6.3.2. Patient derived xenograft model
7. Preclinical CRO Market: By End-Use, 2021-2031, USD (Million)
- 7.1. Market Overview
- 7.2. Growth & Revenue Analysis: 2022 Versus 2031
- 7.3. Market Segmentation
- 7.3.1. Biopharmaceutical Companies
- 7.3.2. Government and Academic Institutes
- 7.3.3. Medical Device Companies
8. North America Preclinical CRO Market, 2021-2031, USD (Million)
- 8.1. Market Overview
- 8.2. Preclinical CRO Market: By Service, 2021-2031, USD (Million)
- 8.3. Preclinical CRO Market: By Model Type, 2021-2031, USD (Million)
- 8.4. Preclinical CRO Market: By End-Use, 2021-2031, USD (Million)
- 8.5.Preclinical CRO Market: By Region, 2021-2031, USD (Million)
- 8.5.1.North America
- 8.5.1.1. U.S.
- 8.5.1.1.1. Preclinical CRO Market: By Service, 2021-2031, USD (Million)
- 8.5.1.1.2. Preclinical CRO Market: By Model Type, 2021-2031, USD (Million)
- 8.5.1.1.3. Preclinical CRO Market: By End-Use, 2021-2031, USD (Million)
- 8.5.1.2. Canada
- 8.5.1.2.1. Preclinical CRO Market: By Service, 2021-2031, USD (Million)
- 8.5.1.2.2. Preclinical CRO Market: By Model Type, 2021-2031, USD (Million)
- 8.5.1.2.3. Preclinical CRO Market: By End-Use, 2021-2031, USD (Million)
- 8.5.1.3. Rest of North America
- 8.5.1.3.1. Preclinical CRO Market: By Service, 2021-2031, USD (Million)
- 8.5.1.3.2. Preclinical CRO Market: By Model Type, 2021-2031, USD (Million)
- 8.5.1.3.3. Preclinical CRO Market: By End-Use, 2021-2031, USD (Million)
- 8.5.1.1. U.S.
- 8.5.1.North America
9. UK and European Union Preclinical CRO Market, 2021-2031, USD (Million)
- 9.1. Market Overview
- 9.2. Preclinical CRO Market: By Service, 2021-2031, USD (Million)
- 9.3. Preclinical CRO Market: By Model Type, 2021-2031, USD (Million)
- 9.4. Preclinical CRO Market: By End-Use, 2021-2031, USD (Million)
- 9.5.Preclinical CRO Market: By Region, 2021-2031, USD (Million)
- 9.5.1.UK and European Union
- 9.5.1.1. UK
- 9.5.1.1.1. Preclinical CRO Market: By Service, 2021-2031, USD (Million)
- 9.5.1.1.2. Preclinical CRO Market: By Model Type, 2021-2031, USD (Million)
- 9.5.1.1.3. Preclinical CRO Market: By End-Use, 2021-2031, USD (Million)
- 9.5.1.2. Germany
- 9.5.1.2.1. Preclinical CRO Market: By Service, 2021-2031, USD (Million)
- 9.5.1.2.2. Preclinical CRO Market: By Model Type, 2021-2031, USD (Million)
- 9.5.1.2.3. Preclinical CRO Market: By End-Use, 2021-2031, USD (Million)
- 9.5.1.3. Spain
- 9.5.1.3.1. Preclinical CRO Market: By Service, 2021-2031, USD (Million)
- 9.5.1.3.2. Preclinical CRO Market: By Model Type, 2021-2031, USD (Million)
- 9.5.1.3.3. Preclinical CRO Market: By End-Use, 2021-2031, USD (Million)
- 9.5.1.4. Italy
- 9.5.1.4.1. Preclinical CRO Market: By Service, 2021-2031, USD (Million)
- 9.5.1.4.2. Preclinical CRO Market: By Model Type, 2021-2031, USD (Million)
- 9.5.1.4.3. Preclinical CRO Market: By End-Use, 2021-2031, USD (Million)
- 9.5.1.5. France
- 9.5.1.5.1. Preclinical CRO Market: By Service, 2021-2031, USD (Million)
- 9.5.1.5.2. Preclinical CRO Market: By Model Type, 2021-2031, USD (Million)
- 9.5.1.5.3. Preclinical CRO Market: By End-Use, 2021-2031, USD (Million)
- 9.5.1.6. Rest of Europe
- 9.5.1.6.1. Preclinical CRO Market: By Service, 2021-2031, USD (Million)
- 9.5.1.6.2. Preclinical CRO Market: By Model Type, 2021-2031, USD (Million)
- 9.5.1.6.3. Preclinical CRO Market: By End-Use, 2021-2031, USD (Million)
- 9.5.1.1. UK
- 9.5.1.UK and European Union
10. Asia Pacific Preclinical CRO Market, 2021-2031, USD (Million)
- 10.1. Market Overview
- 10.2. Preclinical CRO Market: By Service, 2021-2031, USD (Million)
- 10.3. Preclinical CRO Market: By Model Type, 2021-2031, USD (Million)
- 10.4. Preclinical CRO Market: By End-Use, 2021-2031, USD (Million)
- 10.5.Preclinical CRO Market: By Region, 2021-2031, USD (Million)
- 10.5.1.Asia Pacific
- 10.5.1.1. China
- 10.5.1.1.1. Preclinical CRO Market: By Service, 2021-2031, USD (Million)
- 10.5.1.1.2. Preclinical CRO Market: By Model Type, 2021-2031, USD (Million)
- 10.5.1.1.3. Preclinical CRO Market: By End-Use, 2021-2031, USD (Million)
- 10.5.1.2. Japan
- 10.5.1.2.1. Preclinical CRO Market: By Service, 2021-2031, USD (Million)
- 10.5.1.2.2. Preclinical CRO Market: By Model Type, 2021-2031, USD (Million)
- 10.5.1.2.3. Preclinical CRO Market: By End-Use, 2021-2031, USD (Million)
- 10.5.1.3. India
- 10.5.1.3.1. Preclinical CRO Market: By Service, 2021-2031, USD (Million)
- 10.5.1.3.2. Preclinical CRO Market: By Model Type, 2021-2031, USD (Million)
- 10.5.1.3.3. Preclinical CRO Market: By End-Use, 2021-2031, USD (Million)
- 10.5.1.4. Australia
- 10.5.1.4.1. Preclinical CRO Market: By Service, 2021-2031, USD (Million)
- 10.5.1.4.2. Preclinical CRO Market: By Model Type, 2021-2031, USD (Million)
- 10.5.1.4.3. Preclinical CRO Market: By End-Use, 2021-2031, USD (Million)
- 10.5.1.5. South Korea
- 10.5.1.5.1. Preclinical CRO Market: By Service, 2021-2031, USD (Million)
- 10.5.1.5.2. Preclinical CRO Market: By Model Type, 2021-2031, USD (Million)
- 10.5.1.5.3. Preclinical CRO Market: By End-Use, 2021-2031, USD (Million)
- 10.5.1.6. Rest of Asia Pacific
- 10.5.1.6.1. Preclinical CRO Market: By Service, 2021-2031, USD (Million)
- 10.5.1.6.2. Preclinical CRO Market: By Model Type, 2021-2031, USD (Million)
- 10.5.1.6.3. Preclinical CRO Market: By End-Use, 2021-2031, USD (Million)
- 10.5.1.1. China
- 10.5.1.Asia Pacific
11. Latin America Preclinical CRO Market, 2021-2031, USD (Million)
- 11.1. Market Overview
- 11.2. Preclinical CRO Market: By Service, 2021-2031, USD (Million)
- 11.3. Preclinical CRO Market: By Model Type, 2021-2031, USD (Million)
- 11.4. Preclinical CRO Market: By End-Use, 2021-2031, USD (Million)
- 11.5.Preclinical CRO Market: By Region, 2021-2031, USD (Million)
- 11.5.1.Latin America
- 11.5.1.1. Brazil
- 11.5.1.1.1. Preclinical CRO Market: By Service, 2021-2031, USD (Million)
- 11.5.1.1.2. Preclinical CRO Market: By Model Type, 2021-2031, USD (Million)
- 11.5.1.1.3. Preclinical CRO Market: By End-Use, 2021-2031, USD (Million)
- 11.5.1.2. Mexico
- 11.5.1.2.1. Preclinical CRO Market: By Service, 2021-2031, USD (Million)
- 11.5.1.2.2. Preclinical CRO Market: By Model Type, 2021-2031, USD (Million)
- 11.5.1.2.3. Preclinical CRO Market: By End-Use, 2021-2031, USD (Million)
- 11.5.1.3. Rest of Latin America
- 11.5.1.3.1. Preclinical CRO Market: By Service, 2021-2031, USD (Million)
- 11.5.1.3.2. Preclinical CRO Market: By Model Type, 2021-2031, USD (Million)
- 11.5.1.3.3. Preclinical CRO Market: By End-Use, 2021-2031, USD (Million)
- 11.5.1.1. Brazil
- 11.5.1.Latin America
12. Middle East and Africa Preclinical CRO Market, 2021-2031, USD (Million)
- 12.1. Market Overview
- 12.2. Preclinical CRO Market: By Service, 2021-2031, USD (Million)
- 12.3. Preclinical CRO Market: By Model Type, 2021-2031, USD (Million)
- 12.4. Preclinical CRO Market: By End-Use, 2021-2031, USD (Million)
- 12.5.Preclinical CRO Market: By Region, 2021-2031, USD (Million)
- 12.5.1.Middle East and Africa
- 12.5.1.1. GCC
- 12.5.1.1.1. Preclinical CRO Market: By Service, 2021-2031, USD (Million)
- 12.5.1.1.2. Preclinical CRO Market: By Model Type, 2021-2031, USD (Million)
- 12.5.1.1.3. Preclinical CRO Market: By End-Use, 2021-2031, USD (Million)
- 12.5.1.2. Africa
- 12.5.1.2.1. Preclinical CRO Market: By Service, 2021-2031, USD (Million)
- 12.5.1.2.2. Preclinical CRO Market: By Model Type, 2021-2031, USD (Million)
- 12.5.1.2.3. Preclinical CRO Market: By End-Use, 2021-2031, USD (Million)
- 12.5.1.3. Rest of Middle East and Africa
- 12.5.1.3.1. Preclinical CRO Market: By Service, 2021-2031, USD (Million)
- 12.5.1.3.2. Preclinical CRO Market: By Model Type, 2021-2031, USD (Million)
- 12.5.1.3.3. Preclinical CRO Market: By End-Use, 2021-2031, USD (Million)
- 12.5.1.1. GCC
- 12.5.1.Middle East and Africa
13. Company Profile
- 13.1. Covance Inc.
- 13.1.1. Company Overview
- 13.1.2. Financial Performance
- 13.1.3. Product Portfolio
- 13.1.4. Strategic Initiatives
- 13.2. Charles River Laboratories International, Inc.
- 13.2.1. Company Overview
- 13.2.2. Financial Performance
- 13.2.3. Product Portfolio
- 13.2.4. Strategic Initiatives
- 13.3. Syngene International Limited
- 13.3.1. Company Overview
- 13.3.2. Financial Performance
- 13.3.3. Product Portfolio
- 13.3.4. Strategic Initiatives
- 13.4. Eurofins Scientific
- 13.4.1. Company Overview
- 13.4.2. Financial Performance
- 13.4.3. Product Portfolio
- 13.4.4. Strategic Initiatives
- 13.5. PRA Health Sciences, Inc.
- 13.5.1. Company Overview
- 13.5.2. Financial Performance
- 13.5.3. Product Portfolio
- 13.5.4. Strategic Initiatives
- 13.6. Wuxi AppTec
- 13.6.1. Company Overview
- 13.6.2. Financial Performance
- 13.6.3. Product Portfolio
- 13.6.4. Strategic Initiatives
- 13.7. Medpace, Inc.
- 13.7.1. Company Overview
- 13.7.2. Financial Performance
- 13.7.3. Product Portfolio
- 13.7.4. Strategic Initiatives
- 13.8. PPD (Thermo Fisher Scientific, Inc.)
- 13.8.1. Company Overview
- 13.8.2. Financial Performance
- 13.8.3. Product Portfolio
- 13.8.4. Strategic Initiatives
- 13.9. SGA SA
- 13.9.1. Company Overview
- 13.9.2. Financial Performance
- 13.9.3. Product Portfolio
- 13.9.4. Strategic Initiatives
- 13.10. Intertek Group Plc (IGP)
- 13.10.1. Company Overview
- 13.10.2. Financial Performance
- 13.10.3. Product Portfolio
- 13.10.4. Strategic Initiatives
- 13.11. LABCORP
- 13.11.1. Company Overview
- 13.11.2. Financial Performance
- 13.11.3. Product Portfolio
- 13.11.4. Strategic Initiatives
- 13.12. Crown Bioscience
- 13.12.1. Company Overview
- 13.12.2. Financial Performance
- 13.12.3. Product Portfolio
- 13.12.4. Strategic Initiatives
- 13.13. Other Notable Players
- 13.13.1. Company Overview
- 13.13.2. Financial Performance
- 13.13.3. Product Portfolio
- 13.13.4. Strategic Initiatives
List of Tables
- TABLE 1 Global Preclinical CRO Market By Service, 2021-2031, USD (Million)
- TABLE 2 Global Preclinical CRO Market By Bioanalysis and DMPK studies, 2021-2031, USD (Million)
TABLE 3 Global Preclinical CRO Market By Toxicology Testing, 2021-2031, USD (Million)
TABLE 4 Global Preclinical CRO Market By Compound Management, 2021-2031, USD (Million)
TABLE 5 Global Preclinical CRO Market By Chemistry, 2021-2031, USD (Million)
TABLE 6 Global Preclinical CRO Market By Model Type, 2021-2031, USD (Million)
- TABLE 7 Global Preclinical CRO Market By End-Use, 2021-2031, USD (Million)
- TABLE 8 North America Preclinical CRO Market By Service, 2021-2031, USD (Million)
- TABLE 9 North America Preclinical CRO Market By Bioanalysis and DMPK studies, 2021-2031, USD (Million)
TABLE 10 North America Preclinical CRO Market By Toxicology Testing, 2021-2031, USD (Million)
TABLE 11 North America Preclinical CRO Market By Compound Management, 2021-2031, USD (Million)
TABLE 12 North America Preclinical CRO Market By Chemistry, 2021-2031, USD (Million)
TABLE 13 North America Preclinical CRO Market By Model Type, 2021-2031, USD (Million)
- TABLE 14 North America Preclinical CRO Market By End-Use, 2021-2031, USD (Million)
- TABLE 15 U.S. Preclinical CRO Market By Service, 2021-2031, USD (Million)
- TABLE 16 U.S. Preclinical CRO Market By Bioanalysis and DMPK studies, 2021-2031, USD (Million)
TABLE 17 U.S. Preclinical CRO Market By Toxicology Testing, 2021-2031, USD (Million)
TABLE 18 U.S. Preclinical CRO Market By Compound Management, 2021-2031, USD (Million)
TABLE 19 U.S. Preclinical CRO Market By Chemistry, 2021-2031, USD (Million)
TABLE 20 U.S. Preclinical CRO Market By Model Type, 2021-2031, USD (Million)
- TABLE 21 U.S. Preclinical CRO Market By End-Use, 2021-2031, USD (Million)
- TABLE 22 Canada Preclinical CRO Market By Service, 2021-2031, USD (Million)
- TABLE 23 Canada Preclinical CRO Market By Bioanalysis and DMPK studies, 2021-2031, USD (Million)
TABLE 24 Canada Preclinical CRO Market By Toxicology Testing, 2021-2031, USD (Million)
TABLE 25 Canada Preclinical CRO Market By Compound Management, 2021-2031, USD (Million)
TABLE 26 Canada Preclinical CRO Market By Chemistry, 2021-2031, USD (Million)
TABLE 27 Canada Preclinical CRO Market By Model Type, 2021-2031, USD (Million)
- TABLE 28 Canada Preclinical CRO Market By End-Use, 2021-2031, USD (Million)
- TABLE 29 Rest of North America Preclinical CRO Market By Service, 2021-2031, USD (Million)
- TABLE 30 Rest of North America Preclinical CRO Market By Bioanalysis and DMPK studies, 2021-2031, USD (Million)
TABLE 31 Rest of North America Preclinical CRO Market By Toxicology Testing, 2021-2031, USD (Million)
TABLE 32 Rest of North America Preclinical CRO Market By Compound Management, 2021-2031, USD (Million)
TABLE 33 Rest of North America Preclinical CRO Market By Chemistry, 2021-2031, USD (Million)
TABLE 34 Rest of North America Preclinical CRO Market By Model Type, 2021-2031, USD (Million)
- TABLE 35 Rest of North America Preclinical CRO Market By End-Use, 2021-2031, USD (Million)
- TABLE 36 UK and European Union Preclinical CRO Market By Service, 2021-2031, USD (Million)
- TABLE 37 UK and European Union Preclinical CRO Market By Bioanalysis and DMPK studies, 2021-2031, USD (Million)
TABLE 38 UK and European Union Preclinical CRO Market By Toxicology Testing, 2021-2031, USD (Million)
TABLE 39 UK and European Union Preclinical CRO Market By Compound Management, 2021-2031, USD (Million)
TABLE 40 UK and European Union Preclinical CRO Market By Chemistry, 2021-2031, USD (Million)
TABLE 41 UK and European Union Preclinical CRO Market By Model Type, 2021-2031, USD (Million)
- TABLE 42 UK and European Union Preclinical CRO Market By End-Use, 2021-2031, USD (Million)
- TABLE 43 UK Preclinical CRO Market By Service, 2021-2031, USD (Million)
- TABLE 44 UK Preclinical CRO Market By Bioanalysis and DMPK studies, 2021-2031, USD (Million)
TABLE 45 UK Preclinical CRO Market By Toxicology Testing, 2021-2031, USD (Million)
TABLE 46 UK Preclinical CRO Market By Compound Management, 2021-2031, USD (Million)
TABLE 47 UK Preclinical CRO Market By Chemistry, 2021-2031, USD (Million)
TABLE 48 UK Preclinical CRO Market By Model Type, 2021-2031, USD (Million)
- TABLE 49 UK Preclinical CRO Market By End-Use, 2021-2031, USD (Million)
- TABLE 50 Germany Preclinical CRO Market By Service, 2021-2031, USD (Million)
- TABLE 51 Germany Preclinical CRO Market By Bioanalysis and DMPK studies, 2021-2031, USD (Million)
TABLE 52 Germany Preclinical CRO Market By Toxicology Testing, 2021-2031, USD (Million)
TABLE 53 Germany Preclinical CRO Market By Compound Management, 2021-2031, USD (Million)
TABLE 54 Germany Preclinical CRO Market By Chemistry, 2021-2031, USD (Million)
TABLE 55 Germany Preclinical CRO Market By Model Type, 2021-2031, USD (Million)
- TABLE 56 Germany Preclinical CRO Market By End-Use, 2021-2031, USD (Million)
- TABLE 57 Spain Preclinical CRO Market By Service, 2021-2031, USD (Million)
- TABLE 58 Spain Preclinical CRO Market By Bioanalysis and DMPK studies, 2021-2031, USD (Million)
TABLE 59 Spain Preclinical CRO Market By Toxicology Testing, 2021-2031, USD (Million)
TABLE 60 Spain Preclinical CRO Market By Compound Management, 2021-2031, USD (Million)
TABLE 61 Spain Preclinical CRO Market By Chemistry, 2021-2031, USD (Million)
TABLE 62 Spain Preclinical CRO Market By Model Type, 2021-2031, USD (Million)
- TABLE 63 Spain Preclinical CRO Market By End-Use, 2021-2031, USD (Million)
- TABLE 64 Italy Preclinical CRO Market By Service, 2021-2031, USD (Million)
- TABLE 65 Italy Preclinical CRO Market By Bioanalysis and DMPK studies, 2021-2031, USD (Million)
TABLE 66 Italy Preclinical CRO Market By Toxicology Testing, 2021-2031, USD (Million)
TABLE 67 Italy Preclinical CRO Market By Compound Management, 2021-2031, USD (Million)
TABLE 68 Italy Preclinical CRO Market By Chemistry, 2021-2031, USD (Million)
TABLE 69 Italy Preclinical CRO Market By Model Type, 2021-2031, USD (Million)
- TABLE 70 Italy Preclinical CRO Market By End-Use, 2021-2031, USD (Million)
- TABLE 71 France Preclinical CRO Market By Service, 2021-2031, USD (Million)
- TABLE 72 France Preclinical CRO Market By Bioanalysis and DMPK studies, 2021-2031, USD (Million)
TABLE 73 France Preclinical CRO Market By Toxicology Testing, 2021-2031, USD (Million)
TABLE 74 France Preclinical CRO Market By Compound Management, 2021-2031, USD (Million)
TABLE 75 France Preclinical CRO Market By Chemistry, 2021-2031, USD (Million)
TABLE 76 France Preclinical CRO Market By Model Type, 2021-2031, USD (Million)
- TABLE 77 France Preclinical CRO Market By End-Use, 2021-2031, USD (Million)
- TABLE 78 Rest of Europe Preclinical CRO Market By Service, 2021-2031, USD (Million)
- TABLE 79 Rest of Europe Preclinical CRO Market By Bioanalysis and DMPK studies, 2021-2031, USD (Million)
TABLE 80 Rest of Europe Preclinical CRO Market By Toxicology Testing, 2021-2031, USD (Million)
TABLE 81 Rest of Europe Preclinical CRO Market By Compound Management, 2021-2031, USD (Million)
TABLE 82 Rest of Europe Preclinical CRO Market By Chemistry, 2021-2031, USD (Million)
TABLE 83 Rest of Europe Preclinical CRO Market By Model Type, 2021-2031, USD (Million)
- TABLE 84 Rest of Europe Preclinical CRO Market By End-Use, 2021-2031, USD (Million)
- TABLE 85 Asia Preclinical CRO Market By Service, 2021-2031, USD (Million)
- TABLE 86 Asia Preclinical CRO Market By Bioanalysis and DMPK studies, 2021-2031, USD (Million)
TABLE 87 Asia Preclinical CRO Market By Toxicology Testing, 2021-2031, USD (Million)
TABLE 88 Asia Preclinical CRO Market By Compound Management, 2021-2031, USD (Million)
TABLE 89 Asia Preclinical CRO Market By Chemistry, 2021-2031, USD (Million)
TABLE 90 Asia Preclinical CRO Market By Model Type, 2021-2031, USD (Million)
- TABLE 91 Asia Preclinical CRO Market By End-Use, 2021-2031, USD (Million)
- TABLE 92 China Preclinical CRO Market By Service, 2021-2031, USD (Million)
- TABLE 93 China Preclinical CRO Market By Bioanalysis and DMPK studies, 2021-2031, USD (Million)
TABLE 94 China Preclinical CRO Market By Toxicology Testing, 2021-2031, USD (Million)
TABLE 95 China Preclinical CRO Market By Compound Management, 2021-2031, USD (Million)
TABLE 96 China Preclinical CRO Market By Chemistry, 2021-2031, USD (Million)
TABLE 97 China Preclinical CRO Market By Model Type, 2021-2031, USD (Million)
- TABLE 98 China Preclinical CRO Market By End-Use, 2021-2031, USD (Million)
- TABLE 99 Japan Preclinical CRO Market By Service, 2021-2031, USD (Million)
- TABLE 100 Japan Preclinical CRO Market By Bioanalysis and DMPK studies, 2021-2031, USD (Million)
TABLE 101 Japan Preclinical CRO Market By Toxicology Testing, 2021-2031, USD (Million)
TABLE 102 Japan Preclinical CRO Market By Compound Management, 2021-2031, USD (Million)
TABLE 103 Japan Preclinical CRO Market By Chemistry, 2021-2031, USD (Million)
TABLE 104 Japan Preclinical CRO Market By Model Type, 2021-2031, USD (Million)
- TABLE 105 Japan Preclinical CRO Market By End-Use, 2021-2031, USD (Million)
- TABLE 106 India Preclinical CRO Market By Service, 2021-2031, USD (Million)
- TABLE 107 India Preclinical CRO Market By Bioanalysis and DMPK studies, 2021-2031, USD (Million)
TABLE 108 India Preclinical CRO Market By Toxicology Testing, 2021-2031, USD (Million)
TABLE 109 India Preclinical CRO Market By Compound Management, 2021-2031, USD (Million)
TABLE 110 India Preclinical CRO Market By Chemistry, 2021-2031, USD (Million)
TABLE 111 India Preclinical CRO Market By Model Type, 2021-2031, USD (Million)
- TABLE 112 India Preclinical CRO Market By End-Use, 2021-2031, USD (Million)
- TABLE 113 Australia Preclinical CRO Market By Service, 2021-2031, USD (Million)
- TABLE 114 Australia Preclinical CRO Market By Bioanalysis and DMPK studies, 2021-2031, USD (Million)
TABLE 115 Australia Preclinical CRO Market By Toxicology Testing, 2021-2031, USD (Million)
TABLE 116 Australia Preclinical CRO Market By Compound Management, 2021-2031, USD (Million)
TABLE 117 Australia Preclinical CRO Market By Chemistry, 2021-2031, USD (Million)
TABLE 118 Australia Preclinical CRO Market By Model Type, 2021-2031, USD (Million)
- TABLE 119 Australia Preclinical CRO Market By End-Use, 2021-2031, USD (Million)
- TABLE 120 South Korea Preclinical CRO Market By Service, 2021-2031, USD (Million)
- TABLE 121 South Korea Preclinical CRO Market By Bioanalysis and DMPK studies, 2021-2031, USD (Million)
TABLE 122 South Korea Preclinical CRO Market By Toxicology Testing, 2021-2031, USD (Million)
TABLE 123 South Korea Preclinical CRO Market By Compound Management, 2021-2031, USD (Million)
TABLE 124 South Korea Preclinical CRO Market By Chemistry, 2021-2031, USD (Million)
TABLE 125 South Korea Preclinical CRO Market By Model Type, 2021-2031, USD (Million)
- TABLE 126 South Korea Preclinical CRO Market By End-Use, 2021-2031, USD (Million)
- TABLE 127 Latin America Preclinical CRO Market By Service, 2021-2031, USD (Million)
- TABLE 128 Latin America Preclinical CRO Market By Bioanalysis and DMPK studies, 2021-2031, USD (Million)
TABLE 129 Latin America Preclinical CRO Market By Toxicology Testing, 2021-2031, USD (Million)
TABLE 130 Latin America Preclinical CRO Market By Compound Management, 2021-2031, USD (Million)
TABLE 131 Latin America Preclinical CRO Market By Chemistry, 2021-2031, USD (Million)
TABLE 132 Latin America Preclinical CRO Market By Model Type, 2021-2031, USD (Million)
- TABLE 133 Latin America Preclinical CRO Market By End-Use, 2021-2031, USD (Million)
- TABLE 134 Brazil Preclinical CRO Market By Service, 2021-2031, USD (Million)
- TABLE 135 Brazil Preclinical CRO Market By Bioanalysis and DMPK studies, 2021-2031, USD (Million)
TABLE 136 Brazil Preclinical CRO Market By Toxicology Testing, 2021-2031, USD (Million)
TABLE 137 Brazil Preclinical CRO Market By Compound Management, 2021-2031, USD (Million)
TABLE 138 Brazil Preclinical CRO Market By Chemistry, 2021-2031, USD (Million)
TABLE 139 Brazil Preclinical CRO Market By Model Type, 2021-2031, USD (Million)
- TABLE 140 Brazil Preclinical CRO Market By End-Use, 2021-2031, USD (Million)
- TABLE 141 Mexico Preclinical CRO Market By Service, 2021-2031, USD (Million)
- TABLE 142 Mexico Preclinical CRO Market By Bioanalysis and DMPK studies, 2021-2031, USD (Million)
TABLE 143 Mexico Preclinical CRO Market By Toxicology Testing, 2021-2031, USD (Million)
TABLE 144 Mexico Preclinical CRO Market By Compound Management, 2021-2031, USD (Million)
TABLE 145 Mexico Preclinical CRO Market By Chemistry, 2021-2031, USD (Million)
TABLE 146 Mexico Preclinical CRO Market By Model Type, 2021-2031, USD (Million)
- TABLE 147 Mexico Preclinical CRO Market By End-Use, 2021-2031, USD (Million)
- TABLE 148 Rest of Latin America Preclinical CRO Market By Service, 2021-2031, USD (Million)
- TABLE 149 Rest of Latin America Preclinical CRO Market By Bioanalysis and DMPK studies, 2021-2031, USD (Million)
TABLE 150 Rest of Latin America Preclinical CRO Market By Toxicology Testing, 2021-2031, USD (Million)
TABLE 151 Rest of Latin America Preclinical CRO Market By Compound Management, 2021-2031, USD (Million)
TABLE 152 Rest of Latin America Preclinical CRO Market By Chemistry, 2021-2031, USD (Million)
TABLE 153 Rest of Latin America Preclinical CRO Market By Model Type, 2021-2031, USD (Million)
- TABLE 154 Rest of Latin America Preclinical CRO Market By End-Use, 2021-2031, USD (Million)
- TABLE 155 Middle East and Africa Preclinical CRO Market By Service, 2021-2031, USD (Million)
- TABLE 156 Middle East and Africa Preclinical CRO Market By Bioanalysis and DMPK studies, 2021-2031, USD (Million)
TABLE 157 Middle East and Africa Preclinical CRO Market By Toxicology Testing, 2021-2031, USD (Million)
TABLE 158 Middle East and Africa Preclinical CRO Market By Compound Management, 2021-2031, USD (Million)
TABLE 159 Middle East and Africa Preclinical CRO Market By Chemistry, 2021-2031, USD (Million)
TABLE 160 Middle East and Africa Preclinical CRO Market By Model Type, 2021-2031, USD (Million)
- TABLE 161 Middle East and Africa Preclinical CRO Market By End-Use, 2021-2031, USD (Million)
- TABLE 162 GCC Preclinical CRO Market By Service, 2021-2031, USD (Million)
- TABLE 163 GCC Preclinical CRO Market By Bioanalysis and DMPK studies, 2021-2031, USD (Million)
TABLE 164 GCC Preclinical CRO Market By Toxicology Testing, 2021-2031, USD (Million)
TABLE 165 GCC Preclinical CRO Market By Compound Management, 2021-2031, USD (Million)
TABLE 166 GCC Preclinical CRO Market By Chemistry, 2021-2031, USD (Million)
TABLE 167 GCC Preclinical CRO Market By Model Type, 2021-2031, USD (Million)
- TABLE 168 GCC Preclinical CRO Market By End-Use, 2021-2031, USD (Million)
- TABLE 169 Africa Preclinical CRO Market By Service, 2021-2031, USD (Million)
- TABLE 170 Africa Preclinical CRO Market By Bioanalysis and DMPK studies, 2021-2031, USD (Million)
TABLE 171 Africa Preclinical CRO Market By Toxicology Testing, 2021-2031, USD (Million)
TABLE 172 Africa Preclinical CRO Market By Compound Management, 2021-2031, USD (Million)
TABLE 173 Africa Preclinical CRO Market By Chemistry, 2021-2031, USD (Million)
TABLE 174 Africa Preclinical CRO Market By Model Type, 2021-2031, USD (Million)
- TABLE 175 Africa Preclinical CRO Market By End-Use, 2021-2031, USD (Million)
- TABLE 176 Rest of Middle East and Africa Preclinical CRO Market By Service, 2021-2031, USD (Million)
- TABLE 177 Rest of Middle East and Africa Preclinical CRO Market By Bioanalysis and DMPK studies, 2021-2031, USD (Million)
TABLE 178 Rest of Middle East and Africa Preclinical CRO Market By Toxicology Testing, 2021-2031, USD (Million)
TABLE 179 Rest of Middle East and Africa Preclinical CRO Market By Compound Management, 2021-2031, USD (Million)
TABLE 180 Rest of Middle East and Africa Preclinical CRO Market By Chemistry, 2021-2031, USD (Million)
TABLE 181 Rest of Middle East and Africa Preclinical CRO Market By Model Type, 2021-2031, USD (Million)
- TABLE 182 Rest of Middle East and Africa Preclinical CRO Market By End-Use, 2021-2031, USD (Million)
List of Figures
- FIG. 1 Global Preclinical CRO Market: Market Coverage
- FIG. 2 Research Methodology and Data Sources
- FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
- FIG. 4 Global Preclinical CRO Market: Quality Assurance
- FIG. 5 Global Preclinical CRO Market, By Service, 2022
- FIG. 6 Global Preclinical CRO Market, By Model Type, 2022
- FIG. 7 Global Preclinical CRO Market, By End-Use, 2022
- FIG. 8 Global Preclinical CRO Market, By Geography, 2022
- FIG. 9 Market Geographical Opportunity Matrix - Global Preclinical CRO Market, 2022
FIG. 10Market Positioning of Key Preclinical CRO Market Players, 2022
FIG. 11Global Preclinical CRO Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
- FIG. 12 Global Preclinical CRO Market, By Service, 2022 Vs 2031, %
- FIG. 13 Global Preclinical CRO Market, By Model Type, 2022 Vs 2031, %
- FIG. 14 Global Preclinical CRO Market, By End-Use, 2022 Vs 2031, %
- FIG. 15 U.S. Preclinical CRO Market (US$ Million), 2021 - 2031
- FIG. 16 Canada Preclinical CRO Market (US$ Million), 2021 - 2031
- FIG. 17 Rest of North America Preclinical CRO Market (US$ Million), 2021 - 2031
- FIG. 18 UK Preclinical CRO Market (US$ Million), 2021 - 2031
- FIG. 19 Germany Preclinical CRO Market (US$ Million), 2021 - 2031
- FIG. 20 Spain Preclinical CRO Market (US$ Million), 2021 - 2031
- FIG. 21 Italy Preclinical CRO Market (US$ Million), 2021 - 2031
- FIG. 22 France Preclinical CRO Market (US$ Million), 2021 - 2031
- FIG. 23 Rest of Europe Preclinical CRO Market (US$ Million), 2021 - 2031
- FIG. 24 China Preclinical CRO Market (US$ Million), 2021 - 2031
- FIG. 25 Japan Preclinical CRO Market (US$ Million), 2021 - 2031
- FIG. 26 India Preclinical CRO Market (US$ Million), 2021 - 2031
- FIG. 27 Australia Preclinical CRO Market (US$ Million), 2021 - 2031
- FIG. 28 South Korea Preclinical CRO Market (US$ Million), 2021 - 2031
- FIG. 29 Rest of Asia Preclinical CRO Market (US$ Million), 2021 - 2031
- FIG. 30 Brazil Preclinical CRO Market (US$ Million), 2021 - 2031
- FIG. 31 Mexico Preclinical CRO Market (US$ Million), 2021 - 2031
- FIG. 32 Rest of Latin America Preclinical CRO Market (US$ Million), 2021 - 2031
- FIG. 33 GCC Preclinical CRO Market (US$ Million), 2021 - 2031
- FIG. 34 Africa Preclinical CRO Market (US$ Million), 2021 - 2031
- FIG. 35 Rest of Middle East and Africa Preclinical CRO Market (US$ Million), 2021 - 2031
